{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:43:09Z","timestamp":1782513789743,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ygyno.2012.10.016","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T19:16:38Z","timestamp":1351019798000},"page":"171-174","source":"Crossref","is-referenced-by-count":26,"title":["The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma"],"prefix":"10.1016","volume":"128","author":[{"given":"Mohamed A.","family":"Elshaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan R.","family":"Munkarah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared R.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Laser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Cogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.10.016_bb0005","series-title":"Cancer facts & figures 2012","author":"American Cancer Society","year":"2012"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0010","series-title":"Cancer facts & figures for African Americans 2011\u20132012","author":"American Cancer Society","year":"2011"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.11484","article-title":"Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus","volume":"98","author":"Sherman","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2012.10.016_bb0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.24160","article-title":"Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time","volume":"115","author":"Wright","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0025","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2","article-title":"The National Cancer Data Base report on endometrial carcinoma in African-American women","volume":"83","author":"Hicks","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0029-7844(96)00341-9","article-title":"Racial differences in endometrial cancer survival: the Black\/White Cancer Survival Study","volume":"88","author":"Hill","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0035","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1200\/JCO.2003.01.218","article-title":"Differences in treatment and outcome between African-American and White women with endometrial cancer","volume":"21","author":"Randall","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2012.10.016_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0029-7844(99)00381-6","article-title":"Race and clinical outcome in endometrial carcinoma","volume":"94","author":"Connell","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ygyno.2012.10.016_bb0045","first-page":"1431","article-title":"Racial disparity in recurrence among patients with early-stage endometrial cancer","volume":"113","author":"Maxwell","year":"2008","journal-title":"Is recurrence increased in Black patients who receive estrogen replacement therapy? Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2012.10.016_bb0050","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/cncr.22232","article-title":"Racial disparity in survival among patients with advanced\/recurrent endometrial adenocarcinoma. A Gynecologic Oncology Group study","volume":"107","author":"Maxwell","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2012.10.016_bb0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2011.02.006","article-title":"The impact of race on survival in uterine serous carcinoma: a hospital-based study","volume":"121","author":"Al-Wahab","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2012.10.016_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0020-7292(92)90659-7","article-title":"Racial differences in patients with adenocarcinoma of the endometrium","volume":"39","author":"Cronj\u00e9","year":"1992","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.ygyno.2012.10.016_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000421-199612000-00014","article-title":"Age and race as prognostic factors in endometrial carcinoma","volume":"19","author":"Aziz","year":"1996","journal-title":"Am J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2012.10.016_bb0070","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ygyno.2012.10.016_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2011.06.027","article-title":"Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment","volume":"123","author":"Oliver","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2012.10.016_bb0080","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2105\/AJPH.94.12.2104","article-title":"Endometrial cancer: socioeconomic status and racial\/ethnic differences in stage at diagnosis, treatment, and survival","volume":"94","author":"Madison","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ygyno.2012.10.016_bb0085","unstructured":"Robbins JR, Mahan MG, Krajenta RJ, Munkarah AR, Elshaikh MA. The impact of income on clinical outcomes in FIGO stage I\u2013II endometrioid adenocarcinoma of the uterus. Am J Clin Oncol in press [Aug 13, Epub ahead of print]."},{"key":"10.1016\/j.ygyno.2012.10.016_bb0090","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ygyno.2012.10.016_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijrobp.2011.05.052","article-title":"Trend in the utilization of adjuvant vaginal cuff brachytherapy and\/or external beam radiation treatment in stage I and II endometrial cancer: a Surveillance, Epidemiology, and End-Results study","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ygyno.2012.10.016_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajog.2011.09.001","article-title":"Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer","volume":"205","author":"Sharma","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.ygyno.2012.10.016_bb0105","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/cncr.26027","article-title":"Deciphering Surveillance, Epidemiology, and End Results data analysis. Are we seeing the whole picture?","volume":"117","author":"Oliver","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2012.10.016_bb0110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/1097-0142(20010815)92:4<950::AID-CNCR1405>3.0.CO;2-O","article-title":"Health care cost and utilization project analysis of comorbid illness and complications for patients undergoing hysterectomy for endometrial carcinoma","volume":"92","author":"Brooks","year":"2001","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2012.10.016_bb0115","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ejca.2011.03.023","article-title":"Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995\u20132008","volume":"47","author":"Boll","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2012.10.016_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2010.10.038","article-title":"Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?","volume":"120","author":"Fleming","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2012.10.016_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2012.04.013","article-title":"Cardiovascular disease is the leading cause of death among endometrial cancer patients","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2012.10.016_bb0130","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/cncr.10559","article-title":"Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker","volume":"94","author":"Powell","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2012.10.016_bb0135","first-page":"2999","article-title":"Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers","volume":"6","author":"Maxwell","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ygyno.2012.10.016_bb0140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2006.01.041","article-title":"The racial disparity in outcomes in endometrial cancer: could this be explained on a molecular level?","volume":"102","author":"Schimp","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T23:53:03Z","timestamp":1542671583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812008426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0090825812008426"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.10.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}